R&G Pharma: Progress of lawsuits involving the company, its subsidiaries, and actual controllers

R&G Pharma announced that the company recently received a civil application for retrial from the Supreme People's Court, regarding the "Notice of Response to Lawsuit." Zhong Dafang is dissatisfied with the second-instance civil judgment made by the Beijing High People's Court and has applied for a retrial to the Supreme People's Court. As of the date of this announcement, the case has been filed for retrial examination, and the company will fulfill its information disclosure obligations in a timely manner based on the final examination results